Clinical Trial Update: Sidus(TM) Post Market Clinical Follow-up (PMCF) Study

View source ↗

Summary

Update on Zimmer Biomet's Sidus PMCF post-market clinical follow-up study, indicating the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Inflammatory Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Sidus

Snippet

Sponsor: Zimmer Biomet | Conditions: Non-inflammatory Degenerative Joint Disease (NIDJD), Avascular Necrosis | Status: ACTIVE_NOT_RECRUITING